Trials / Recruiting
RecruitingNCT06116253
Advanced Diffusion Imaging in Renal Cancer Patients
Advanced Diffusion Imaging in Renal Cancer Patients: Oncologic Control and Renal Functional Reserve
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 21 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to apply advanced diffusion imaging in a two-pronged assessment of renal mass patients: (1) characterization of lesion malignancy and subtype, and (2) prediction of renal function stability or decline following partial nephrectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Magnetic Resonance Imaging (MRI) Scan | Participants will undergo a 1-hour research MRI scan. |
| DRUG | Tc-99m Pentetate | Participants will receive radioisotope (99mTc-DTPA) injection (5 mCi) during 3-5 hour scanning session to estimate measured glomerular filtration rate (mGFR). |
Timeline
- Start date
- 2022-12-01
- Primary completion
- 2028-12-01
- Completion
- 2028-12-01
- First posted
- 2023-11-03
- Last updated
- 2025-06-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06116253. Inclusion in this directory is not an endorsement.